Value Added Medicines: Rethink, reinvent & optimise medicines – 31 May 2016 at European Parliament

Christian Siebert (European Commission) speech at the Biosimilar Medicines conference 2016

https://youtube.com/watch?v=INzZyNYPScw+

Biosimilar Medicines Handbook (new edition)

IMS Institute – Biosimilar Report

EAHP satellite on Biosimilar medicines

Maarten Van Baelen – Intro + Niklas Ekman – Biosimilars from the perspective of an EU regulator


pdf_file1
Maarten Van Baelen

pdf_file1
Niklas Ekman

Arnold Vulto – Biosimilars concerns of prescribers and how to address them as a hospital pharmacist

pdf_file1
Arnold Vulto

Paul Cornes – Biosimilars – can we do without them

pdf_file1
Paul Cornes

Please find  the report of the satellite symposium held at the EAHP conference here.

Joint 22nd EGA and 19th IGBA Annual Conference (8-10 June 2016)

JOINT 22nd EGA and 19th IGBA ANNUAL CONFERENCE (8-10 June 2016)

EGA-EBG Summary Position Regarding the WHO Biologic Qualifier Proposal (INN Working Doc. 14.342)

Sans-titre-4

Jacek Glinka – EGA Becomes Medicines for Europe

Factsheet: What is a Biosimilar Medicine

6. Biosimilar Medicines_OnBM-1

Factsheet: About the Biosimilar Medicines Group

5. Biosimilar Medicines_AboutBM-1